CONMED Corporation
CNMD
$52.29
$1.142.23%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.56% | -7.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.56% | -7.14% | |||
| Cost of Revenue | 9.93% | -5.08% | |||
| Gross Profit | 3.96% | -8.67% | |||
| SG&A Expenses | -4.85% | 10.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.71% | 1.95% | |||
| Operating Income | 55.69% | -56.54% | |||
| Income Before Tax | 289.98% | -82.42% | |||
| Income Tax Expenses | 419.44% | -83.45% | |||
| Earnings from Continuing Operations | 254.89% | -82.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 254.89% | -82.12% | |||
| EBIT | 55.69% | -56.54% | |||
| EBITDA | 32.03% | -40.86% | |||
| EPS Basic | 255.11% | -82.15% | |||
| Normalized Basic EPS | 86.78% | -66.49% | |||
| EPS Diluted | 263.16% | -82.41% | |||
| Normalized Diluted EPS | 87.20% | -66.43% | |||
| Average Basic Shares Outstanding | -0.08% | 0.16% | |||
| Average Diluted Shares Outstanding | -0.31% | 0.02% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.72% | 4.60% | |||